SynopsisMesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mou.....
SynopsisThe global Growth Hormone Pen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Growth Hormone Pen is estimated to increase fro.....
SynopsisMicafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal.....
SynopsisHerpes Simplex Virus Testing Kits is the procedure to test if the patient have the Herpes Simplex Virus The global Herpes Simplex Virus Testing Kits market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The marke.....
SynopsisRivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Riva.....
SynopsisThe global High-Throughput Sequencing (HTS) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of High-Throughput Sequencing (HTS) in various end use indus.....
SynopsisVagal nerve stimulation or vagus nerve stimulation (VNS) is a treatment method that involves delivering electrical impulses to the vagus nerve. Vegas nerve acts as a translator between gut and brain. Gut uses the vagus nerve like a walkie-talkie and translates.....
SynopsisFebrile neutropenia, one of the most severe complications during cancer chemotherapy, is the development of fever with infection signals. The global Febrile Neutropenia market was valued at US$ million in 2023 and is anticipated to reach US$ million by .....
SynopsisThe global Vertical Emergency Eyewash Station market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Vertical Emergency Eyewash Stat.....
SynopsisThe global 3D Cell Culture Microplate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for 3D Cell Culture Microplate is estimated.....








